Patient perspectives on recall period and response options in patient-reported outcome measures for chronic rhinosinusitis symptomatology: An international multi-centered study
- PMID: 37788156
- DOI: 10.1002/alr.23280
Patient perspectives on recall period and response options in patient-reported outcome measures for chronic rhinosinusitis symptomatology: An international multi-centered study
Abstract
Background: Existing patient-reported outcome measures (PROMs) for chronic rhinosinusitis (CRS) use a variety of recall periods and response scales to assess CRS symptom burden. Global perspectives of CRS patients regarding optimal recall periods and response scales for CRS PROMs are unknown.
Methods: This was a multi-center, cross-sectional study recruiting 461 CRS patients from sites across the United States, Saudi Arabia, New Zealand, and Austria. Participants chose which CRS symptom recall period (1 day, 2 weeks, 1 month, >1 month) was most reflective of their current disease state and upon which to best base treatment recommendations (including surgery). Participants also chose which of six response scales (one visual analogue scale and five Likert scales ranging from four to eight items) was easiest to use, understand, and preferred.
Results: A plurality of participants (40.0%) felt their CRS symptoms' current state was best reflected by a 1-month recall period. However, most patients (56.9%) preferred treatment recommendations to be determined by symptoms experienced over a >1 month period. The four- and five-item Likert scales were the easiest to understand (26.0% and 25.4%, respectively) and use (23.4% and 26.7%, respectively). The five-item (26.4% rating it most preferred and 70.9% rating it preferred) and four-item Likert (22.3% rating it most preferred and 56.4% rating it preferred) response scales were most preferred.
Conclusion: Future PROMs for CRS should consider assessment of symptoms over a 1-month period and use a four- or five-item Likert response scale to reflect global patient preferences. These findings also inform interpretation of current CRS PROMs.
Keywords: PROM; chronic rhinosinusitis; design; patient‐reported outcome; recall; response; scale.
© 2023 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.
Similar articles
-
Patient perspectives on recall period and response options in patient-reported outcome measures for chronic rhinosinusitis symptomatology: A pilot study.Clin Otolaryngol. 2021 Sep;46(5):1021-1027. doi: 10.1111/coa.13774. Epub 2021 Apr 21. Clin Otolaryngol. 2021. PMID: 33780598
-
Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis.Int Forum Allergy Rhinol. 2017 Feb;7(2):128-134. doi: 10.1002/alr.21866. Epub 2016 Nov 7. Int Forum Allergy Rhinol. 2017. PMID: 28177596 Free PMC article.
-
Patient-Reported Outcome Measures in Rhinitis and Chronic Rhinosinusitis.J Allergy Clin Immunol Pract. 2024 Oct;12(10):2574-2582. doi: 10.1016/j.jaip.2024.06.049. Epub 2024 Jul 14. J Allergy Clin Immunol Pract. 2024. PMID: 39004415 Review.
-
Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs).Patient. 2023 May;16(3):201-221. doi: 10.1007/s40271-022-00611-w. Epub 2023 Feb 14. Patient. 2023. PMID: 36786931 Free PMC article.
-
Patient-reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease status.Int Forum Allergy Rhinol. 2025 Jan;15(1):27-35. doi: 10.1002/alr.23435. Epub 2024 Sep 13. Int Forum Allergy Rhinol. 2025. PMID: 39269197 Free PMC article.
Cited by
-
[The nose is essential].HNO. 2024 Apr;72(4):223-224. doi: 10.1007/s00106-024-01444-9. Epub 2024 Mar 22. HNO. 2024. PMID: 38519753 German. No abstract available.
-
Chronic rhinosinusitis with nasal polyps (CRSwNP) symptom verbal response scales: content validity testing for use in adults with CRSwNP.J Patient Rep Outcomes. 2024 Dec 20;8(1):152. doi: 10.1186/s41687-024-00827-4. J Patient Rep Outcomes. 2024. PMID: 39704924 Free PMC article.
References
REFERENCES
-
- Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11:213‐739.
-
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1‐464.
-
- Tarasidis GS, DeConde AS, Mace JC, et al. Cognitive dysfunction associated with pain and quality of life in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 2015;5:1004‐1009.
-
- Hoehle LP, Phillips KM, Bergmark RW, Caradonna DS, Gray ST, Sedaghat AR. Symptoms of chronic rhinosinusitis differentially impact general health‐related quality of life. Rhinology. 2016;54:316‐322.
-
- Cox DR, Ashby S, DeConde AS, et al. Dyad of pain and depression in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 2016;6:308‐314.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources